ラサギリンの持続放出性製剤およびその使用

Title:

ラサギリンの持続放出性製剤およびその使用

Document Type and Number:

Japanese Patent JP6770564

Kind Code:

B2

Abstract:

The present invention provides various pharmaceutical compositions, in particular for oral administration, formulated for extended release of active compounds useful in the treatment of neurodegenerative diseases, in particular Parkinson's disease, and injuries to the nervous system. The active compound comprised within these compositions is preferably selected from N-propargyl-1-aminoindan, an enantiomer thereof, or a pharmaceutically acceptable salt thereof, more preferably rasagiline or a pharmaceutically acceptable salt thereof.

More Like This:

JPS62190156	SYMMETRIC O-SUBSTITUTED DIOXIMES OF BENZENE-FUSED BETA-DIKETOCYCLOALKYLENE, MANUFACTURE AND APPLICATION TO DRUG
JPH0543522	STILBENE DERIVATIVE AND PHARMACEUTICAL COMPOSITION HAVING TUMOR-SUPPRESSING EFFECT AND CONTAINING THE DERIVATIVE
JP2003095927	DOSAGE FORM OF BRITTLE COATING OF SOFT CORE

Inventors:

Sera yoram
Rivena Nurit
Ramensdorf Ichuck
Madmon thomer

Application Number:

JP2018216973A

Publication Date:

October 14, 2020

Filing Date:

November 20, 2018

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Pharma Two Be Limited

International Classes:

A61K31/135; A61K9/20; A61K9/24; A61K9/48; A61K47/04; A61K47/10; A61K47/32; A61K47/36; A61P25/00; A61P25/16; A61P25/28

Domestic Patent References:

JP6440662B2
JP2008507586A

Attorney, Agent or Firm:

Masayuki Masabayashi
Hayashi Ichiyoshi

Previous Patent: 自転車ホイール

Next Patent: 内部ナノ粒子を有する骨格マトリックス